Prevalence,Natural History,Prognosis Factor,QualityofLife,Health Care Consumption and Social Consequences of Symptomatic Knee and Hip Osteoarthritis in France

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

878 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-04-30

Study Completion Date

2019-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the project is to assemble and to follow on a 10-year period a nationwide representative sample of lower limb OA patients.

General objectives: To document the natural history and to identify predictive factors of the evolution and consequences of hip and knee OA in terms of pain, functional disability, structural damage, quality of life, autonomy, medical and health care use and cost of disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Quality of Care for Knee and Hip Osteoarthritis in Elderly Patients

NCT04170218

Knee Osteoarthritis Hip Osteoarthritis Quality of Healthcare +1 more

UNKNOWN

New Tool of Subjective and Objective Functional Evaluation and the Quality of Life After Arthroplastic Surgery of the Hip and the Knee Assisted or Not by Computer and Mini-invasive Arthroplasty

NCT00894218

Hip Arthritis Knee Arthritis

TERMINATED NA

Determinants of Functional Ability, Perceived Health, and Interaction With Multimorbidity in Hip and Knee Osteoarthritis

NCT02887092

Osteoarthritis

COMPLETED

Comorbidities and Indirect Health State Utility in Hip and Knee Osteoarthritis

NCT02879890

Osteoarthritis

COMPLETED

Screening for Hip and Knee Osteoarthritis in the General Population: Predictive Value of a Questionnaire and Prevalence Estimates

NCT00522080

Hip and Knee Osteoarthritis

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Osteoarthritis Knee Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study specific procedure

X-rays, biological samples and medical information about osteoarthritis

Group Type EXPERIMENTAL

X-rays

Intervention Type PROCEDURE

X-rays (hip and knee) every 2 years

biological samples

Intervention Type BIOLOGICAL

biological sample (blood and urine) every 2 years

medical information about osteoarthritis

Intervention Type OTHER

several questionnaires about pain and function (WOMAC), physical activity (MAQ), quality of life (generic SF-36 and OA specific OAKHQOL/AMIQUAL), comorbidities (FCI), mental status (MMS), heath status (GHQ 28) and health resource consumption

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

X-rays

X-rays (hip and knee) every 2 years

Intervention Type PROCEDURE

biological samples

biological sample (blood and urine) every 2 years

Intervention Type BIOLOGICAL

medical information about osteoarthritis

several questionnaires about pain and function (WOMAC), physical activity (MAQ), quality of life (generic SF-36 and OA specific OAKHQOL/AMIQUAL), comorbidities (FCI), mental status (MMS), heath status (GHQ 28) and health resource consumption

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male and female aged between 40 and 75 years
* symptomatic hip or knee, uni or bilateral OA with clinical diagnosis confirmed by a medical physician and satisfying ACR classification criteria
* Representative of prevalent cases in France at the cohort set-up time

Exclusion Criteria

* presence of hip or knee joint replacement surgery
* comorbidities severe enough to affect quality of life significantly or likely to induce a high health care consumption independently of OA
* an history of osteotomy
* Patello-femoral osteoarthritis without tibio-femoral osteoarthritis
* Other joint diseases of the target joints
* adult under legal protection or not able to consent

Minimum Eligible Age

40 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No